Back to Search
RICHIE BAST, M.D.
M.D.
Family Medicine Physician
NPI: 1649256587Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
14854(AZ)
Research & Publications (20)
ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins.
PMID 19435463·Biosci Rep·2009
8-other
Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
PMID 19007973·Gynecol Oncol·2009
8-other
Role of noncollinear magnetization for the first-order electric-dipole hyperpolarizability at the four-component Kohn-Sham density functional theory level.
PMID 19154021·J Chem Phys·2009
8-other
Project Zero Delay: a process for accelerating the activation of cancer clinical trials.
PMID 19652061·J Clin Oncol·2009
8-other
A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.
PMID 19671744·Mol Cancer Ther·2009
7-preclinical
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
PMID 18851871·Gynecol Oncol·2009
3-trial
MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.
PMID 19517469·Cancer·2009
8-other
The biology of ovarian cancer: new opportunities for translation.
PMID 19461667·Nat Rev Cancer·2009
6-review
CA125/MUC16 is dispensable for mouse development and reproduction.
PMID 19262696·PLoS One·2009
7-preclinical
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
PMID 18286529·Cancer·2008
4-observational
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
PMID 19033662·J Clin Invest·2008
7-preclinical
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.
PMID 19029832·Cell Cycle·2008
7-preclinical
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
PMID 18637025·Differentiation·2008
7-preclinical
Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007.
PMID 18096210·Gynecol Oncol·2008
8-other
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
PMID 18061248·Gynecol Oncol·2008
8-other
Static and frequency-dependent dipole-dipole polarizabilities of all closed-shell atoms up to radium: a four-component relativistic DFT study.
PMID 18224633·Chemphyschem·2008
8-other
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers.
PMID 18176935·Mol Carcinog·2008
8-other
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
PMID 19042984·Clin Chem·2008
6-review
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
PMID 18495222·Gynecol Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 110 E. 1ST SOUTH STREET
SAINT JOHNS, AZ 85936 - Phone
- (928) 337-4802
Quick Facts
- NPI
- 1649256587
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile